Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development
10/03/2026 10:34
March 10 (Reuters) - CK Life Sciences Intl (Holdings) Inc 0775.HK: ESTABLISHES SEQUENCIO THERAPEUTICS FOR CANCER VACCINE DEVELOPMENT Further company coverage: 0775.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development